BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Scottish Court of Session Decisions


You are here: BAILII >> Databases >> Scottish Court of Session Decisions >> PETITON OF BURNS PHARMACY LTD FOR JUDICIAL REVIEW [2023] ScotCS CSOH_60 (13 September 2023)
URL: http://www.bailii.org/scot/cases/ScotCS/2023/2023_CSOH_60.html
Cite as: 2023 GWD 37-302, [2023] ScotCS CSOH_60, [2023] CSOH 60

[New search] [Printable PDF version] [Help]


OUTER HOUSE, COURT OF SESSION
[2023] CSOH 60
P943/22
OPINION OF LORD HARROWER
In the petition of
BURNS PHARMACY LIMITED
Petitioner
for judicial review of a decision of the National Appeal Panel
Petitioners: Lindsay KC; Cameron McKenna Nabarro Olswang LLP
Second Respondent: James; NHS Scotland Central Legal Office
14 September 2023
The issues
[1]
This petition for judicial review concerns the provision of pharmaceutical services in
Monkton. The village is served by four pharmacies located in Prestwick to the south, and
four others located in Troon and Dundonald to the north. The third respondent to the
petition, Mr Sean Manson, wished to provide pharmaceutical services in Monkton village
itself, initially, from premises at 21 Main Street. In 2017, he applied to the Ayrshire and
Arran Health Board, who is the second respondent, to be included on the pharmaceutical
list, being the list required to be kept by the board inter alia of the names of persons who
undertake to provide pharmaceutical services in its area, and the addresses of the premises
from which they undertake to provide them. Only if the board is satisfied that the provision
2
of pharmaceutical services at the premises named in the application is necessary or desirable
in order to secure adequate provision of pharmaceutical services in the neighbourhood may
the application be granted. Mr Manson's 2017 application had a complex procedural
history, but it was ultimately refused by the board, and his appeal from the board's decision
was dismissed. However, in 2021 Mr Manson applied in respect of different premises at the
Old Monkton Primary School. On this occasion, the board granted his application.
[2]
The petitioner is Burns Pharmacy Limited. It provides pharmaceutical services from
premises in Prestwick. It objected to Mr Manson's inclusion on the list, and appealed to the
National Appeal Panel, who is the first respondent. After sundry procedure, described in
more detail below, the panel refused the petitioner's appeal. The petitioner now makes this
application for judicial review of the panel's decision, complaining that the panel failed to
recognise that the board had misunderstood and misapplied the relevant test, and had failed
to provide adequate reasons. In particular, in its assessment of the adequacy of existing
services, the board had failed to have regard to evidence of the availability of parking at or
near the existing pharmacies. Further, in assessing the necessity or desirability of the
application, it failed to consider adequately or at all the viability of pharmaceutical services
being provided from the premises named in the application, wrongly speculating on the
extent to which it might be supported by population growth in the neighbourhood.
[3]
The matter came before me for a substantive hearing, at which both the petitioner
and the board were represented. There was no appearance for either the panel or
Mr Manson. Before setting out the background in more detail, it is necessary to summarise
the terms of the relevant legislation.
3
The legislation
[4]
Applications to be included on the pharmaceutical list are governed by the National
Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 (SI 2009/183) ("the
regulations"). Regulation 5(1) requires the relevant health board to maintain a list of the
names of persons who undertake to provide pharmaceutical services in its area, the
pharmaceutical services they undertake to provide, and the addresses and opening hours of
the premises from which they undertake to provide them.
[5]
In terms of regulation 5(2), any person who wishes to be included in the
pharmaceutical list must first complete a pre-application and joint consultation with the
board in accordance with regulation 5A. The purpose of the pre-application and joint
consultation is inter alia to assess whether there is already adequate provision of
pharmaceutical services in the neighbourhood and to establish "the level of support of
residents in the neighbourhood to which the application relates" (reg 5A(2)). Following the
consultation exercise, a joint consultation analysis report ("CAR") must be produced setting
out the methods of engagement used to undertake the consultation, the list of questions and
responses, the number and category of respondents and the level of support "for the issues
consulted upon" (regs 5A(4) and 5(5)). Once this has been completed, the application itself,
if proceeded with, must be completed in accordance with the relevant form prescribed in
Schedule 2 to the regulations.
[6]
Regulation 5(10) provides that the application shall be assessed in accordance with
the procedures set out in Schedule 3 to the regulations, and granted by the board,
"only if it is satisfied that the provision of pharmaceutical services at the premises
named in the application is necessary or desirable in order to secure adequate
provision of pharmaceutical services in the neighbourhood in which the premises are
located by persons whose names are included in the pharmaceutical list".
4
Schedule 3 includes provisions for notification to inter alios any person whose name is
included on the list and whose interests may in the opinion of the board be significantly
affected by the application if granted (Sch 3, para 1). Schedule 3 then provides that in
considering an application, the board shall have regard to the following matters (Sch 3,
para 3(1)):
"(a)
the pharmaceutical services already provided in the neighbourhood of the
premises named in the application by persons whose names are included in a
pharmaceutical list;
(b)
pharmaceutical services to be provided in the neighbourhood at these
premises by any person whose name is included in the provisional
pharmaceutical list;
(c)
any representations received by the Board under paragraph 1;
(d)
any information available to the Board which, in its opinion, is relevant to the
consideration of the application;
(e)
the consultation analysis report submitted in accordance with regulation 5A;
(f)
the pharmaceutical care services plan; and
(g)
the likely long term sustainability of the pharmaceutical services to be
provided by the applicant."
[7]
The Pharmacy Practices Committee ("the PPC") exercises the board's functions
regarding applications for entry to the list (Sch 3, para 3(7); Sch 4, paras 1-2). The PPC is
comprised of seven members: a chair who is a member of the board; three pharmacists; and
three laypersons (Sch 4, para 3). Any member with an interest in a matter to be determined
at the meeting to determine the application, or any association with a person who has a
personal interest in such matters, must declare that interest (Sch 4, para 4).
[8]
The PPC may determine the application without hearing oral representations where
it is satisfied that these are unnecessary (Sch 3, para 3(2)). In other cases, it shall convene a
meeting to determine the application and give reasonable notice to the applicant and those
that have submitted written representations to enable them to participate (Sch 3, para 3(3)).
5
[9]
Applications are to be determined, except in exceptional circumstances, within six
weeks of receipt of the CAR (Sch 4, para 3(4)-(5)). In its determination, the PPC must
include (Sch 3, para 3(6)):
"(a)
a summary of the consultation analysis report submitted in accordance with
regulation 5A;
(b)
an explanation of how the consultation analysis report was taken into account
in arriving at the decision, with regard to the tests under regulation 5(10), as
applicable; and
(c)
the reasons for its decision."
[10]
The applicant and any interested party who participated in the PPC proceedings (ie
any interested party that made written representations) is entitled to appeal and an appeal
lies to the National Appeal Panel (Sch 3, para 5 and para 5(7A)). However, appeals may
only be taken on restricted grounds (Sch 3, para 5):
"(2A) The grounds of appeal are limited to where the circumstances in sub-
paragraph (2B) have occurred or where the Board has erred in law in its
application of the provisions of these Regulations.
(2B)
The circumstances are--
(a)
there has been a procedural defect in the way the application has been
considered by the Board;
(b)
there has been a failure by the Board to properly narrate the facts or
reasons upon which their determination of the application was based;
or
(c)
there has been a failure to explain the application by the Board of the
provisions of these Regulations to those facts."
[11]
The panel is comprised of three members: a chair who must be an advocate, solicitor
or solicitor-advocate with no previous medical experience; a pharmacist; and a board-
appointed member with no previous medical experience (Sch 4, paras 9-11). Members of the
panel are also required to make the same declaration of interest as is required by members
of the PPC (Sch 4, para 12).
[12]
Notices of appeal are referred to the chair of the panel (Sch 3, para 5(4)). Upon
receipt, the chair has three options (Sch 3, para 5(5)-(6)). First, he must dismiss the appeal if
6
of the opinion that it discloses no reasonable grounds or is otherwise frivolous or vexatious.
Secondly, he must remit the decision to the PPC for reconsideration if of the opinion that
there has been an error in terms of Schedule 3, paragraph 5(2B). Thirdly, in any other case,
he must convene a panel to determine the appeal.
[13]
Any decision made by the chair, or the panel where convened to determine the
appeal, is final (Sch 3, para 5(5) and 6(5)). The only remedy against such a decision is an
application for judicial review.
Background
The first application
[14]
As already noted above, Mr Manson had first made an application to be included in
the pharmaceutical list in respect of premises at 21 Main Street, Monkton, in 2017. In that
application he had maintained that existing services were inadequate, having regard to
difficulties residents faced in accessing the nearest pharmacies in Troon and Prestwick. He
referred to the poor availability of parking spaces, heavy congestion, unreliable public
transport and lack of safety in travelling to existing pharmacies on foot. The CAR had
indicated that a pharmacy was desirable in Monkton. The responses to the CAR indicated
that residents wanted it. It was envisaged that there would be future housing developments
in Monkton. While planning permission had not been granted, the land had been zoned and
it was clear that the developments would happen.
[15]
Initially, in December 2017, the PPC granted the application. It noted that there were
no pharmaceutical services in the neighbourhood. For those without a car, in particular the
elderly and young people with children, the pharmacies in Prestwick and Troon were
inaccessible. The petitioner and Boots (UK) Ltd both appealed. On 3 April 2018 the panel
7
allowed the appeal, and remitted the application to the board for consideration by a fresh
PPC absent any of the members who participated at the initial hearing.
[16]
The fresh PPC hearing took place on 28 August 2018. On 10 September 2018 it
refused the application. It found that existing services were adequate and the new
pharmacy was neither necessary nor desirable. In relation specifically to adequacy, the PPC
referred to census information from 2011 indicating that the population of Monkton was
healthy, wealthy and mobile. There was a low need to access services. It acknowledged that
the CAR indicated excellent public support for the proposed pharmacy, but noted there was
no evidence of complaints to the board regarding existing services. It further observed that
many respondents to the CAR were either complaining on behalf of others who allegedly
could not access existing services or merely said that services were "not convenient". Site
visits undertaken by the PPC also indicated widespread access to cars among residents in
Monkton. The parking situation at existing pharmacies was "not impossible". Bus transport
was available. Existing providers offered delivery services, telephone consultations and
home visits; face-to-face patient consultation was not always necessary. The site visits
indicated that residents of Monkton were not using the amenities located there. Residents
were not "forced to make special trips" to collect prescriptions, but would be required to
travel to Prestwick, Troon, or other surrounding towns in any event, for example, in order to
shop at supermarkets.
[17]
Mr Manson then appealed to the panel, but on 5 January 2019 the panel dismissed
the appeal.
8
The second application
[18]
Mr Manson's second application, the subject of the present proceedings, was made
on 5 August 2021, in respect of premises at Old Monkton Primary School, which is located
near the premises forming the basis of his first application. The PPC hearing to determine
the application took place on 2 November 2021.
[19]
On 23 November the PPC granted the application. Due to the outbreak of the
pandemic, "visits" to the site had been conducted virtually ie using, among other materials,
digital online maps. The PPC attached significant weight to the CAR due to its high
response rate. An overwhelming majority of residents (92.04%) supported the opening of
the new pharmacy. In terms of the adequacy of existing services, the main issue was
accessibility. Travel on foot was unsafe and unfeasible. Public transport was costly and
unreliable. It was almost irrelevant that residents had access to cars due to parking
difficulties at the existing pharmacies. The personal experiences of members of the PPC
indicated that there were difficulties in contacting pharmacies by telephone. Many people
did not feel comfortable with triage services and it was desirable that face-to-face contact be
encouraged and increased. The first phase of a development had now been completed and
future developments were probable. The CAR indicated that this expansion would result in
an overwhelming need for services. The growing population would also ensure viability.
The impact of the pandemic meant that there was less need to travel outwith the village, for
example, to access GP services. The PPC did not agree with the portrayal of the population
as young, healthy, wealthy and mobile. The responses in the CAR were largely supportive.
A majority of respondents, most of whom were residents, considered the proposals
appropriate. This included location, opening times and the list of services to be provided.
The proposed pharmacy was to have four dedicated parking spaces. Concerns regarding
9
traffic in the area were thus unwarranted. In any event, most residents would be able to
access the pharmacy on foot. The PPC concluded:
"29.
The Decision
29.1.
Following the withdrawal of Mr Connolly, Ms Gallagher and
Ms Mitchell in accordance with the procedure on applications contained
within Paragraph 7, Schedule 4 of the National Health Service
(Pharmaceutical Services) (Scotland) Regulations 1909, as amended, the
Committee, for the reasons set out above, concluded that current provision to
the neighbourhood was inadequate in terms of access.
29.1.1. Having ascertained that pharmacy services to the defined neighbourhood
were inadequate, consideration was given to whether the proposed
application was necessary or desirable to secure adequate provision of
pharmaceutical services for the neighbourhood.
29.1.2. Committee members concluded that the proposed application was necessary
in order to secure adequate pharmaceutical services for the reasons outlined
above."
[20]
The petitioner, Boots, and H & K Willis Ltd appealed. They collectively advanced six
grounds. Only grounds 1, 5 and 6 are relevant for present purposes. The first was that the
PPC had failed to state the grounds upon which it had concluded that existing services were
inadequate. The fifth and sixth grounds related to matters which it was said the PPC ought
not to have taken into account, being the personal experience of members regarding
difficulties in contacting existing pharmacies and additional information which had not been
available at the hearing.
[21]
On 28 February 2022 the panel allowed the appeal in respect of the first ground. It
remitted the matter to the PPC "to more fully explain its reasoning as to why it concluded
that the existing service [was] inadequate" (para 4.1.9). The panel noted that the PPC's
decision in relation to inadequacy of existing provision had been based on issues of access
only (para 4.1.3). The panel acknowledged that each application required to be considered
on its own merits, and that "a previous finding of adequacy, even a recent one, will not
10
prevent the PPC from concluding that the current services are inadequate" (para 4.1.6).
However, it concluded, "in light of the proximity and similarities between the current and
the earlier application", that it was "incumbent upon the PPC to provide sufficiently clear
reasoning as to why it [had] reached a different conclusion from its earlier decision"
(para 4.1.6). It need not address its earlier decision directly, but its reasoning ought to be
"clearly understood" (para 4.1.6). The PPC was directed, in particular:
"to set out clearly its reasoning including the evidence relied upon, as to why the
issues with parking resulted in the conclusion that the existing services [were]
inadequate" (para 4.1.9).
[22]
It was also open to the PPC to clarify the factual position underpinning grounds 5
and 6. In respect of the former, the panel's view was that this had not been a factor in the
PPC's decision. As to the latter, it was understood that the material in question had not
formed part of the application papers but had been part of the hearing papers. Remittal to
the PPC was in the following terms:
"5.1.
For the reasons set out above, I consider that the appeals are successful in
respect of ground of appeal 1. I shall therefore refer the matter back to the PPC to
clarify its decision. In doing so, I should emphasise that I have not concluded that
the PPC has reached the wrong conclusion. It is not my role to do so. However,
when clarifying its decision, the PPC should not feel constrained by its original
decision. If after further consideration, it reaches a different conclusion it is free to
do so. Equally, as I have not concluded that its original decision was wrong, it is free
to abide by its original decision but must simply express its reasons more fully and
clearly."
[23]
The PPC reconvened as originally constituted on 1 June 2022, and issued its
refreshed decision on 14 June 2022, maintaining its prior decision granting the application.
In its refreshed decision, it noted that it had revisited the evidence to familiarise itself once
again with the case and explore its original reasoning. It agreed that all of the content of the
original decision should form part of its refreshed decision. The PPC then turned to address
all six of the grounds of appeal. It noted that its assessment regarding the viability of the
11
proposed pharmacy was based upon the anticipated growth in the population, assessed by
reference to the completion of the first phase of a development by Persimmon homes
comprising 292 homes. It noted that no weight had been placed on members' statements as
to their personal experiences, or on the additional material. Addressing the grounds which
formed the basis of the remittal, the PPC stated:
"30.1.9 Turning to the grounds of appeal 1, 4.1.1 to 4.1.9, the PPC reviewed the
previous discussion in order to provide greater clarity surrounding its decision and
the reasoning for this with the following additions:-
Access ­
the PPC noted as per discussion at 28.3.4, page 86 comments made in the
CAR which noted that the bus services had been described as `unreliable',
`infrequent', `inconsistent' and `buses from Troon deciding not to visit
Monkton because they are behind schedule'. The PPC placed weight on the
evidence noted in the CAR and considered this represented poor public
transport.
the PPC noted as per discussion at 28.3.4, page 86 the costs of travelling by
bus were noted as `£3.60 into Prestwick and £5.40 into Troon'. The PPC
considered that public transport was costly for the residents of Monkton.
the PPC noted as per discussion at 28.3.4, page 86 that those with `mobility
issues had difficulty getting on and off buses as did parents with prams and
young children'. As `it was not feasible for residents to access existing
pharmaceutical services on foot both in terms of the time it would take and
because of safety concerns' the PPC considered that this represented access
issues for the residents of Monkton to existing pharmaceutical services.
the PPC noted as per discussion at 28.3.4, page 86 that whilst `the majority of
the population had access to personal transport with 81.3% having access to
one or more cars' following individual site visits by the PPC it had been
considered that parking at existing pharmacies was `not readily available'.
The PPC added in addition to their observations weight was placed on the
comments in the CAR which `reflected parking difficulties at existing
pharmacies'. The PPC considered that residents opted to take the bus to
avoid parking in Prestwick and Troon and considered access to cars `was
almost irrelevant as parking was difficult.'
The PPC noted poor public transport which was deemed to be costly and unreliable,
mobility and safety concerns regarding access on foot and time taken to walk to
12
existing pharmacies combined with recognised parking difficulties observed by the
PPC and comments made in the CAR.
30.1.10 The reconvened PPC had given due consideration to more fully explain the
reasoning as to why it concluded that the existing service is inadequate, the evidence
relied upon, and to why the issues with parking resulted in the conclusion that the
existing services are inadequate and addressed the points raised by the National
Appeal Panel.
3
Decision
31.1
Following the withdrawal of Mr Connolly, Ms Gallagher and Ms Mitchell in
accordance with the procedure on applications contained within Paragraph 7,
Schedule 4 of the National Health Service (Pharmaceutical Services) (Scotland)
Regulations 1909, as amended, the Committee taking into account all of the
information available, and for the reasons set out in the original decision combined
with the additional clarity provided at 30.1.1 to 30.1.10, pages 91 to 93, concluded
that it remained the view of the Committee that the provision of pharmaceutical
services to the neighbourhood was inadequate in terms of access.
Having ascertained that pharmacy services to the defined neighbourhood were
inadequate, consideration was given to whether the proposed application was
necessary or desirable to secure adequate provision of pharmaceutical services for
the neighbourhood.
Committee members concluded that the proposed application was necessary to
secure adequate pharmaceutical services for the reasons outlined above."
The decision under challenge
[24]
The petitioner, along with Boots, appealed to the panel. On 10 August 2022 the panel
dismissed the appeal. This is the decision under challenge in the present application for
judicial review. The appellants had advanced four grounds. In summarising the reasons for
its decision, I have referred only to the first and third grounds of appeal, since the other two
formed no part of the petitioner's submissions in the present proceedings.
[25]
The first ground was that the PPC had failed adequately to set out its reasons for
concluding that the existing service was inadequate, in particular insofar as it related to the
inadequacy of parking at existing pharmacies. The panel referred to the PPC's expanded
13
reasons at paragraph 30.1.9 of its decision, where it had explained that its conclusion was
based on individual site visits, and the responses to the CAR. The reason that vehicular
access had been described as "close to irrelevant" was that residents opted to take the bus
due to difficulties with parking. The PPC had set out its rationale for concluding that the
availability of access via the bus service was inadequate (para 4.1). The panel concluded that
the PPC's reasoning must be reasonably clear to anyone familiar with the underlying facts
and circumstances on which the decision was based. The PPC was not required to address
each issue or each adminicle of evidence. The panel warned against reasons challenges
being used as a "back door" to challenging the correctness of the PPC's decision (para 4.2).
[26]
The third ground was that the PPC had not demonstrated that the proposed
pharmacy would be viable. The panel considered this was misconceived. It was not for the
PPC to demonstrate the viability of the proposed pharmacy. Rather, viability was one factor
that the PPC was required to consider when assessing whether it was necessary or desirable
to grant the application (para 4.8). The PPC's reasoning was entirely clear. The likely
increase in population caused by imminent development would provide an adequate
customer base to support the proposed pharmacy. The PPC, as an expert body, was best
placed to assess viability (para 4.9).
Submissions
The petitioner
[27]
Counsel for the petitioner adopted its note of argument. The panel had erred by
failing to recognise errors in the PPC's decision. The panel had conducted only a limited
analysis of the terms of the PPC's decision. It simply stated that the decision was sufficiently
clear. In upholding the PPC's decision, the panel had acted unlawfully et separatim
14
unreasonably. Given the nature of the challenge, it was necessary for the court to consider
the PPC's decision, albeit that this was not the decision directly under challenge. In doing
so, according to senior counsel, in his oral submissions at the substantive hearing, the court
should be cautious about accepting late reasons (Chief Constable of Lothian and Borders v
Lothian and Borders Police Board 2005 SLT 315, Lord Reed at paras 65, 70).
[28]
The panel failed to recognise that the PPC in its refreshed decision had
misunderstood and misapplied each of the stages of the test as required by regulation 5(10).
So far as adequacy was concerned, the PPC ought to have first considered whether existing
provision in the relevant neighbourhood was adequate and, if it was, that was an end of the
matter (Lloyds Pharmacy Ltd v National Appeal Panel 2004 SC 703, Lord Drummond Young,
para 8). Only if it concluded that existing provision was inadequate did the issue of whether
the proposed pharmacy was necessary or desirable arise. There was no spectrum of
adequacy. Either services were adequate or they were not (Ibid, para 9). There was evidence
"readily available to the PPC", including maps, photographs and oral and written
submissions from the 2 November hearing, indicating available parking at or near
pharmacies in Troon and Prestwick. This was a relevant and material consideration that it
was not clear whether the PPC took into account. Supplementing these written submissions
at the substantive hearing, senior counsel argued that the PPC had had given too much
weight to the CAR, and, with limited exceptions, had not "engaged" with the evidence from
interested parties. The CAR was not a "popularity contest"; nor was it in the nature of a
planning report or an expert report: it was, he said, a "record of anecdotal comments made
by consultees".
[29]
In any event, the PPC failed to explain why parking difficulties were so severe as to
render existing provision inadequate. Senior counsel referred to the panel's observation, in
15
remitting the index application to the PPC, that the situation regarding parking would have
to be "particularly severe in order materially to hinder access" (para 4.1.8). This had not
been addressed by the PPC in its refreshed decision. There had been no material change in
parking facilities since the 2017 application, which the PPC had accepted were adequate at
that stage. The PPC had failed to provide adequate and comprehensible reasons to explain
why they were now considered inadequate, as it had been required to do by the panel in its
remit. If anything, the evidence indicated that bus services had improved since the previous
decision.
[30]
So far as the second stage of the test was concerned, the necessity or desirability of a
proposed pharmacy did not automatically follow from a finding that existing services were
inadequate. Viability was an important factor and was live before the PPC. Proposed
developments should not have been taken into account by the PPC when assessing likely
increases in population (see the guidance issued in Appendix A of NHS Circular
PCA (P) 7 (2011), mirroring Lloyds Pharmacy Ltd v National Appeal Panel supra, para 10). The
developments relied upon by the applicant were not probable future developments or fixed
plans. No planning application had been made in respect of one of the developments and
planning permission had been refused in respect of the other with no appeal taken against
that decision.
[31]
The petitioner moved the court to grant orders of declarator and reduction in relation
to the panel's decision of 10 August 2022, refusing the petitioner's appeal, on the basis that it
was unlawful et separatim unreasonable.
16
The board
[32]
The board challenged the competency of a number of points now taken in the
petition. For example, there had been no submission to the panel about the PPC having
allegedly taken into account speculative housing developments. Nor were there any
complaints made to the panel regarding the CAR or the conclusions which could properly
be drawn from it. It was not now open to the petitioner to take these points. To permit it do
so would be to allow a direct challenge to the PPC's decision. Any errors by the PPC were
only relevant insofar as they gave rise to an error on the part of the panel. The panel could
not be criticised for failing to recognise errors that had not been raised with it in the grounds
of appeal.
[33]
In any event, it was clear from the terms of the refreshed decision that the PPC
understood and applied the two-stage test. Services were inadequate due to accessibility.
The CAR provided compelling evidence regarding these difficulties. Counsel for the board
urged me to have regard to the affidavit of Linda Semple, chair of the PPC, which, he said,
was entirely consistent with the PPC's decisions (cf Chief Constable, Lothian and Borders
Police v Lothian and Borders Police Board supra, Lord Reed at para 70). She confirmed that at
least some of the evidence regarding parking, that the petitioner contended was "readily
available" to the PPC, was not in fact put before it. It was incumbent upon the petitioner to
make its case and place before the PPC all evidence on which it intended to rely. It did not.
The PPC could not be criticised for failing to have regard to material never placed before it
(Tayside RC v Secretary of State for Scotland 1996 SLT 473, Lord President (Hope), 480D). The
weight to be attributed to evidence that was before the PPC was a matter for the PPC,
subject only to review on Wednesbury grounds (R (Khatun) v London Borough of
Newham [2005] QB 37, Laws LJ, para 35). It was also of little significance that parking spaces
17
existed. The issues for those without cars remained. The petitioner's challenge regarding
adequacy amounted to a factual dispute with the conclusions reached by the PPC.
[34]
Having found the existing provision to be inadequate, it was inevitable that the
provision of pharmaceutical services would be necessary to make up the shortfall. There
was considerable discussion about viability before the PPC. The PPC took account of the
evidence and submissions and considered that the Persimmon Homes development would
result in approximately 629 additional residents in the neighbourhood. That would amount
to roughly a 50% increase in the population with an obvious and significant impact on the
demand for services. There was nothing speculative about this development. The PPC was
entitled to conclude on this basis that the pharmacy would be viable. Indefinite viability
was not necessary. On this matter, Ms Semple had confirmed that the PPC based their
discussion on "completed and delivered new housing, not proposed, whatever the status of
the applications for further development".
[35]
The conclusions that the PPC reached on the application were reasonably open to it
on the evidence. It relied not only on the CAR, but also on site visits that it had carried out.
All of this had to be placed in the context of the PPC's function as a specialist tribunal (Lloyds
Pharmacy Ltd supra, Lord Drummond Young, paras 9 and 11). Its decisions were not to be
subjected to unduly critical analysis. The court ought to have proceeded on the assumption
that it was probable that the PPC got it right. Deference ought to be shown unless there
were clear errors in the decision (AH (Sudan) v Secretary of State for the Home
Department [2008] 1 AC 678, Lord Bingham of Cornhill, para 19 and Baroness Hale of
Richmond, para 30).
[36]
The board moved the court to refuse the petition.
18
Decision
Adequacy
[37]
The "central point", as the petitioner put it, in this application for judicial review is
that the parking facilities "had not changed to any material extent" since Mr Manson's first
application. "If the parking facilities did not render the existing provision inadequate at the
time of [the first application]", the petitioner asked, "why [did] they render it inadequate
now?" The PPC's "complete failure" to engage with this point "demonstrate[d] that they
[had] failed to apply the first part of the two stage test in Regulation 5(10)(a) correctly" (note
of argument, paras 28-31).
[38]
Of course, the PPC is not bound by its own earlier decision in relation to a different
application. As the panel pointed out in its decision of 28 February 2022, remitting the
second application back to the PPC,
"Each application must be considered on its own merits and a previous finding of
adequacy, even a recent one, will not prevent the PPC from concluding that the
current services are inadequate" (para 4.1.6).
It is quite true that the panel went on to say that, "in light of the proximity and similarities"
between the two applications, "it is incumbent on the PPC to provide sufficiently clear
reasoning as to why it has reached a different conclusion from its earlier decision".
However, the panel immediately qualified that by saying, "This does not necessarily require
it to address its [earlier] decision directly but does require its reasoning to be clearly
understood" (Ibid).
[39]
The qualification is important, since it makes it clear that the panel did not require
the PPC to make any express reference to the previous decision of the PPC, or any part of it,
so long as its reasoning was "clearly understood". By "clearly understood", I take it that the
panel meant "clearly understandable" by the reasonable well-informed reader, or, as the
19
panel itself put it, in its decision of 10 August 2022, "reasonably clear to a person who is
familiar with the underlying facts and circumstances on which the decision is based"
(para 4.3). In particular, the PPC was "not required to address each issue raised before it or
address and explain its position in relation to all adminicles of evidence before it" (para 4.3).
The petitioner took no issue with these statements of principle. What I take from them is
that, while the PPC were not required to make any mention of its own earlier decision on
adequacy of access to existing pharmacies, it would have to be reasonably clear to anyone
familiar with the underlying facts and circumstances why its refreshed decision differed
from the PPC's earlier decision on that particular issue.
[40]
Having been represented at the hearings in relation to both applications, the
petitioner would of course have been familiar with the underlying facts and circumstances.
It would have been aware that the PPC in both cases agreed with the applicant regarding
what constituted the neighbourhood, in particular, that it included the Adamton estate. It
would have been aware that the PPC in both cases agreed that walking from Monkton
village to the existing pharmacies was impractical. But it would also have been reasonably
clear that the differently constituted PPCs reached different conclusions on the key aspects
of their decisions regarding adequacy of access.
[41]
Take parking. In relation to the first application, the PPC considered that parking in
Prestwick and Troon, though "not ideal" was "not impossible" (para 19.15). Contrast the
conclusion of the PPC in relation to the second application that parking at existing
pharmacies was "not readily available". It would also have been reasonably clear that the
PPCs reached different conclusions regarding the adequacy of public transport. Again in
relation to the first application, the PPC considered that the bus services were reasonably
frequent, and while they acknowledged the high cost of a return fare, they noted that
20
concessionary fares were available to those "most likely to use pharmacy services"
(para 19.17). Contrast the conclusions of the PPC in relation to the second application that
public transport was both poor and costly.
[42]
It would also have been reasonably clear to anyone familiar with the underlying facts
and circumstances that the differently constituted PPCs had reached their different
conclusions on these matters on the basis of what were, at least to some extent, quite
different evidential considerations. The PPC considering the second application reached
their conclusion on the inadequacy of parking following individual site visits by PPC
members. This was necessarily an evidential basis not available to the PPC considering the
first application. Moreover, it was clear that the PPC that considered the first application
harboured significant reservations regarding the CAR results. Respondents' complaints
were about mere inconvenience rather than inadequacy, and were not based directly on
their own first-hand experience (para 19.13). However, this tendency to relegate the
evidential status of the CAR to mere hearsay (reflected also in senior counsel's dismissal of
the CAR responses as being "anecdotal") was not shared by the PPC that considered the
second application. This may have been due in part to the obvious fact that the CARs for
each application were entirely separate documents based on entirely separate surveys. Be
that as it may, it would have been reasonably clear to anyone familiar with the underlying
facts and circumstances that the PPC considering the second application placed weight on
the comments in the CAR regarding both parking difficulties at and public transport to the
existing pharmacies (paras 28.3.4, 30.1.9).
[43]
It might be objected that, if the PPC's initial reasoning were as clear as I have
suggested, then it is not clear why the panel considered it necessary to remit the matter back
to the PPC in the first place. Further, in its decision remitting the matter back to the PPC, the
21
panel had drawn particular attention to the PPC's conclusion that, although over 80% of
households had access to a car, "issues around parking" rendered that factor "almost
irrelevant" (para 4.1.7). And, while parking in town centres might regularly be
"challenging", the panel required the PPC to address in detail why parking difficulties were
"so unusually severe" as to justify the conclusion that the service as a whole was inadequate
(para 4.1.8).
[44]
Certainly, in its refreshed decision, the PPC appear to have made quite a point of
drawing the panel's attention to reasoning that had already been set out in its original
decision. This is obvious from the continual references in paragraph 30.1.9 to the original
discussion at paragraph 28.3.4. However, even if there had been nothing substantively new
in its refreshed decision, I would have been slow to dismiss its refreshed decision as merely
a cosmetic exercise. Paragraph 28.3.4 is a relatively complex and rather lengthy paragraph.
Breaking the discussion up into discrete bullet points, as the decision does at
paragraph 30.1.9, would have assisted in making its reasoning reasonably clear. And of
course it was specifically in order for the PPC to provide greater clarity of reasoning that the
panel remitted the matter back to it in the first place.
[45]
More importantly, however, the reasoning in paragraph 30.1.9 did go beyond the
original reasoning in at least one significant respect. In paragraph 28.3.4, the PPC's
criticisms of public transport were confined to observing that it was, in summary, both poor
and costly. In its refreshed decision, however, the PPC had gone further and concluded that
residents "opted to take the bus to avoid parking in Prestwick and Troon" (para 30.1.9, final
bullet point). In other words, the PPC made it clear that it did not regard the deficiencies of
the public transport service as an issue whose relevance was confined to the minority of
residents, approximately 20% of the population of Monkton, who had no car. On the
22
contrary, the PPC concluded that even residents with cars would prefer to use a public
transport service that respondents to the CAR regarded as unreliable, infrequent and
expensive, rather than run the risk of not being able to find a parking space at or near the
existing pharmacies. To anyone familiar with the underlying facts and circumstances, this
additional reasoning made explicit what had only been implicit in the PPC's comment that
having access to a car was "almost irrelevant". In doing so, it also made explicit why the
PPC considered the inadequacies of parking at existing pharmacies to be "unusually
severe".
[46]
In the decision under challenge, the panel had regard to the PPC's additional
reasons. It drew attention specifically to the PPC's conclusion that residents "opted to take
the bus due to difficulties with parking" (para 4.2). The panel concluded that the PPC had
reached a decision that was "sufficiently clear" (paras 4.2, 4.4). In my opinion, for the
reasons I have given, it was entitled to reach that conclusion. Senior counsel referred me to
Chief Constable, Lothian and Borders Police v Lothian and Borders Police Board, where Lord Reed
observed inter alia that the court should be cautious about accepting late reasons, where
these have been supplied either voluntarily or in response to a court order. However, the
present case is one where the panel rather than the court ordered and then accepted late
reasons. Even if the panel were considered to be under a duty to be similarly cautious about
accepting late reasons, senior counsel did not suggest that it had been in breach of such a
duty. If he had, I would have rejected that argument. This was not a case where entirely
new reasons were being put forward, but rather one where the PPC made explicit what was
already implicit in its own earlier decision.
[47]
Nor is there any basis for asserting that either the PPC or the panel misunderstood or
misapplied the statutory test, or failed to have regard to the evidence. The relevant
23
component parts of the statutory test, and the differences between them, were clearly set out
throughout the PPC's decision, and more particularly in the dispositive part of its decision
(para 31.1). I would also agree with the panel when it said that the PPC was not required to
address each issue or address and explain its position in relation to all adminicles of
evidence before it (para 4.3). The PPC clearly set out in its decision all the evidence and
submissions that it had received. One cannot conclude merely from a failure to address any
particular issue or adminicle of evidence that it had not been considered by the PPC. On the
contrary, one should assume that it had considered it, unless its decision or its reasons
suggest otherwise (Gillies Ramsay Diamond v PJW Enterprises Ltd 2004 SC 430, Lord President
(Gill), para 28). They do not.
[48]
Paragraph 17 of the petition contained a list of "evidence" that the petitioner alleged
was "readily available" to the PPC but not considered by it. In her affidavit, the PPC's chair,
Ms Semple, confirmed that some of this information was before it, and recorded by the PPC
in the minutes (notably at paras 7.1.16 and 12.26). To that extent, it falls into the category
just discussed of evidence, which it can be assumed that the PPC considered unless its
decision or reasons suggest otherwise. To the extent that the information listed in
paragraph 17 of the petition was not mentioned in the minutes, Ms Semple confirmed that it
was neither submitted to nor considered by the PPC, either as originally constituted or as
reconstituted for the purposes of reconsidering its decision. To that extent, the information
now relied on by the petitioner cannot properly be described as "evidence" at all. As noted
above, the regulations provide that the board must have regard to "any information
available to [it] which, in its opinion, is relevant to consideration of the application" (Sch 3,
para 3). I did not understand senior counsel to go so far as to suggest that this placed an
onus on the PPC to identify available or "readily available" information that had not been
24
submitted to it by parties. If he were making this submission, I would have rejected it. In
my view, the regulations simply make it clear that the PPC is not confined to considering
only such information as has been submitted to it by parties.
[49]
To conclude this aspect of the case, I would agree with the panel where it stated that,
in reality, the petitioner seeks to mount a "back door" challenge to the correctness of the
PPC's decision (para 4.3).
Necessity or desirability
[50]
I can deal with this ground more briefly by saying that I agree with the submissions
of the board.
[51]
I would add only this regarding the board's argument based on competency. In its
grounds of appeal from the PPC's refreshed decision, under the heading "viability", the
petitioner made reference to "the needs of the existing local community" and "population
and demographics". It made no reference to proposed developments within the
neighbourhood or, specifically, to the PPC having wrongly taken account of the allegedly
speculative nature of certain developments on population growth. In its decision, the panel
not only considered the PPC's reasoning "entirely clear". It also referred to the PPC having
considered the "likely increase in population caused by imminent development", and
concluded that this would provide "an adequate population base to support the proposed
pharmacy" (para 4.9). In other words, even though the impact of proposed development on
the viability of the proposed pharmacy had not been raised in the grounds of appeal, the
panel indicated that it was perfectly aware, not only that the issue had been raised before the
PPC, but that the PPC had concluded that the development was imminent rather than
speculative. In my view, the PPC was entitled to reach that conclusion, for the reasons given
25
by the board. But more importantly, in the context of what is necessarily a challenge to the
panel's - rather than the PPC's - decision, the petitioner had simply failed to provide the
panel with any basis upon which to reach any different conclusion. It is difficult to see why
the panel should now be criticised for not considering arguments that were never before it.
Had there been anything of substance in this ground of review, then I would have rejected
the argument as incompetent, the petitioner not having raised the allegedly speculative
nature of specific developments in its grounds of appeal to the panel.
Disposal
[52]
I shall sustain the second and third pleas-in-law for the board, repel the petitioner's
second plea-in-law, and refuse to grant the petitioner's craves for declarator and reduction
of the panel's decision of 10 August 2022. I shall reserve any question of expenses.


BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/scot/cases/ScotCS/2023/2023_CSOH_60.html